We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

107 hedge funds and large institutions have $1.21B invested in Heron Therapeutics in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 42 increasing their positions, 22 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,441% more call options, than puts

Call options by funds: $33.4M | Put options by funds: $2.17M

91% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 22

24% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 25

14% more capital invested

Capital invested by funds: $1.06B → $1.21B (+$149M)

5% more funds holding

Funds holding: 102 → 107 (+5)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
107
Holders Change
+5
Holders Change %
+4.9%
% of All Funds
2.81%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
31
Increased
42
Reduced
22
Closed
25
Calls
$33.4M
Puts
$2.17M
Net Calls
+$31.3M
Net Calls Change
-$53.5M

Top Buyers

1
JHIU
Janus Henderson Investors US
Colorado
+$14.7M
2
KCM
Kingdon Capital Management
New York
+$10.2M
3
BC
Broadfin Capital
New York
+$9.89M
4
Citadel Advisors
Citadel Advisors
Florida
+$8.8M
5
State Street
State Street
Massachusetts
+$8.74M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$18.4M
2
Group One Trading
Group One Trading
Illinois
-$6.32M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6.02M
4
PHS
PFM Health Sciences
California
-$4.95M
5
SM
Sabby Management
Florida
-$4.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$5.47M -$164K -6,125 -3%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$5.39M -$6.02M -225,056 -53%
DCM
28
Driehaus Capital Management
Illinois
$4.2M +$1.52M +57,013 +57%
TA
29
Teachers Advisors
New York
$4.09M +$26K +973 +0.6%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$3.94M +$722K +27,004 +22%
SFM
31
Sphera Funds Management
Israel
$3.6M +$2.27M +85,000 +170%
PAM
32
Panagora Asset Management
Massachusetts
$3.44M +$1.15M +43,072 +50%
HT
33
HAP Trading
New York
$3.22M +$3.23M +120,616 New
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$3.01M +$3.01M +112,720 New
TI
35
Turner Investments
Pennsylvania
$2.83M +$467K +17,470 +20%
BIM
36
BlackRock Investment Management
Delaware
$2.74M +$9.84K +368 +0.4%
Charles Schwab
37
Charles Schwab
California
$2.69M +$342K +12,776 +14%
TCIM
38
TIAA CREF Investment Management
New York
$2.67M -$336K -12,559 -11%
SCM
39
Sio Capital Management
New York
$2.66M +$2.67M +99,772 New
LOAMU
40
Lombard Odier Asset Management (USA)
New York
$2.46M -$684K -25,562 -22%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$2.42M +$2.17M +81,200 +864%
GC
42
Guggenheim Capital
Illinois
$2.25M +$959K +35,848 +74%
OAM
43
Oxford Asset Management
United Kingdom
$2.21M +$2.14M +80,036 New
BGIM
44
Brandywine Global Investment Management
Pennsylvania
$2.16M +$2.16M +80,950 New
FO
45
FT Options
Illinois
$1.9M +$1.9M +71,049 New
Deutsche Bank
46
Deutsche Bank
Germany
$1.86M -$901K -33,707 -33%
MCM
47
Moore Capital Management
New York
$1.74M +$1.74M +65,000 New
Axa
48
Axa
France
$1.54M +$1.54M +57,660 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$1.45M +$26.7K +1,000 +2%
Morgan Stanley
50
Morgan Stanley
New York
$1.39M -$704K -26,324 -34%
1
2
3 4 5

HRTX Hedge Fund Activity: Q4 2015 in Review

107 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2015, worth a combined $1.21B — up 14% from $1.06B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new HRTX positions and 25 closed out — a net gain of 6 holders — while 42 added to existing stakes and 22 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $14.7M. The largest seller was Goldman Sachs, cutting an estimated $18.4M.

  • 107 institutional investors held Heron Therapeutics (HRTX) as of Q4 2015, up from 102 in Q3 2015.
  • Funds reported $1.21B of Heron Therapeutics stock for Q4 2015, up 14% quarter-over-quarter.
  • 31 funds opened new Heron Therapeutics positions in Q4 2015 and 25 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2015 was Janus Henderson Investors US, an estimated $14.7M added.
  • The largest Heron Therapeutics seller in Q4 2015 was Goldman Sachs, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2015.